Article
Evaluation of a combinatorial cell engineering approach to overcome apoptotic effects in XBP-1(s) expressing cells.
Journal of biotechnology - 15 Apr 2010
Becker Eric, Florin Lore, Pfizenmaier Klaus, Kaufmann Hitto
Abstract excerpt
Genetic engineering of producer cell lines for production of therapeutic antibodies in order to increase the yield of production processes remains a continuing challenge. Recently it was shown that heterologous expression of the active, spliced form of human X-box binding protein 1 (XBP-1(s)) can increase the amount of secreted protein products in mammalian cell culture processes. However, a prerequisite for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
